219 related articles for article (PubMed ID: 8822200)
1. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
Gulli LF; Palmer KC; Chen YQ; Reddy KB
Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
[TBL] [Abstract][Full Text] [Related]
2. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
6. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
Johannessen LE; Knardal SL; Madshus IH
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):599-606. PubMed ID: 9895307
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
9. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells.
Toyoda M; Gotoh N; Handa H; Shibuya M
Biochem Biophys Res Commun; 1998 Sep; 250(2):430-5. PubMed ID: 9753647
[TBL] [Abstract][Full Text] [Related]
10. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
11. Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines.
Dangles V; Féménia F; Lainé V; Berthelemy M; Le Rhun D; Poupon MF; Levy D; Schwartz-Cornil I
Cancer Res; 1997 Aug; 57(16):3360-4. PubMed ID: 9269996
[TBL] [Abstract][Full Text] [Related]
12. Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
Harper ME; Goddard L; Glynne-Jones E; Assender J; Dutkowski CM; Barrow D; Dewhurst OL; Wakeling AE; Nicholson RI
Prostate; 2002 Jun; 52(1):59-68. PubMed ID: 11992620
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells.
Ohtsubo M; Gamou S; Shimizu N
Oncogene; 1998 Feb; 16(6):797-802. PubMed ID: 9488044
[TBL] [Abstract][Full Text] [Related]
15. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR
J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
17. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
20. Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1.
Skarpen E; Johannessen LE; Bjerk K; Fasteng H; Guren TK; Lindeman B; Thoresen GH; Christoffersen T; Stang E; Huitfeldt HS; Madshus IH
Exp Cell Res; 1998 Aug; 243(1):161-72. PubMed ID: 9716460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
